Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menjugate in Premature and Non-Premature Infants
NCT00310674Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal group c conjugate vaccine in Meningococcal disease serogroup C (MenC), sponsored by Novartis. Started Sep 2004; status: completed.
02
Drugs
meningococcal group c conjugate vaccine
03
Conditions
Meningococcal disease serogroup C (MenC)
Beyond the preview
Go deeper on NCT00310674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310674.